Ethics of modifying the mitochondrial genome Annelien L. Bredenoord, PhD University Medical Center Utrecht Department of Medical Humanities

Slides:



Advertisements
Similar presentations
Applications of HGP Genetic testing Forensics. Testing for a pathogenic mutation in a certain gene in an individual that indicate a persons risk of developing.
Advertisements

M ITOCHONDRIAL GENOME REPLACEMENT IN UNFERTILIZED OOCYTES FOR TREATMENT OF INHERITED MT DNA DISEASE Shoukhrat Mitalipov 1.
What Should You Know and Be Doing About Genome Privacy? Ellen Wright Clayton, MD, JD Center for Biomedical Ethics and Society Vanderbilt University.
Biomarkism: taming the revolution? May 12 th 2014 PSI Conference David Lovell St George’s Medical School University of London.
Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
BIO TECHNOLOGY 10th Grade - Biology. BIOTECHNOLOGY Land, Air, Water & Minerals Definition : The application of technology utilizing the characteristics.
Examining Genetics/Genomics and Technology from a Human Rights Perspective Bonnie Holaday PhD, RN, FAAN.
Research ethics in The Netherlands dr Annelien Bredenoord & prof dr Hans van Delden UMC Utrecht Julius Center The Netherlands
An Update in Genetics of Epilepsy
Genetic Engineering.
 Chromosome—A string like, gene- containing molecule in the nucleus of a cell  Gene—The fundamental unit of biological inheritance  Genome—An organism’s.
Introduction to Genetics
Fragile x syndrome By Jordon Nagel.
Living with mitochondrial disease and responses to novel (and controversial) reproductive technologies Dr Rebecca
What’s in a name? Identifying multiple representations of women who provide eggs for mitochondrial research. Erica Haimes and Ken Taylor PEALS Research.
Miri Seminar Tufts University April 18, 2014 Genetically Designed Babies & Mitochondrial Disease.
DESIGNER BABIES By Soraya and Hayley. WHAT ARE DESIGNER BABIES?
Modes of selection on quantitative traits. Directional selection The population responds to selection when the mean value changes in one direction Here,
Treuman Katz Center for Pediatric Bioethics Conference Banking Biological Samples for Pediatric Research Jeffrey R. Botkin, M.D., M.P.H. Professor.
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Nucleus Mitochondria Chromo- somes. Mitochondrial Diseases Organs with high energy needs tend to be most severely affected e.g. muscle, brain, eyes,
Aristotle How Should We Live?. Summary of What Will Come  The selection (Nicomachean Ethics, Bks. I and II) begins with Aristotle describing ethics as.
Ethical Issues in the Use of Animals in Xenotransplantation Rui-Peng LEI Center for Bioethics Central China University of Science & Technology Wuhan, China.
Genetic advances will only be acceptable if their application is carried out ethically, with due regard to autonomy, justice, education and the beliefs.
What is a Clinical Trial (alpha version) John M. Harris Jr., MD President Medical Directions, Inc.
The Human Genome and Gene Technologies
Nature and Nurture in Psychology Module 3. Behavior Genetics: the study of the relative power and limits of genetic and environmental influences on behavior.
The Introduction of Allergenic Foods and the Development of Reported Wheezing and Eczema in Childhood: The Generation R Study Tromp IIM, Kiefte-de Jong.
Cohort Study. Objectives To discuss cohort study designs To discuss data from some cohort studies.
Genetic Engineering Chapter 15. Selective Breeding Allowing only animals with wanted characteristics to breed.
2.7 – Genetics and Behaviour. How many chromosomes pairs are in every human cell? Where does each one in the pair come from? 23 pairs. One set from each.
1 Demystifying the Examination of Stem Cell-Related Inventions Remy Yucel, Ph.D. Supervisory Patent Examiner Technology Center 1600 United States Patent.
Ewe were always on my mind….
Rachel Liao, PhD Coordinator of the Clinical Working Group and the BRCA Challenge demonstration project for the Global Alliance for Genomics and Health.
What is gene therapy? Do now: In your own words,
Biotechnology AQLIMA ALI & ATIKAH MSU.
The French Perspective The law 1994 Civil code: Art
Human Embryos and Gene-editing Research and regulation in China Prof. Zhihong Xu, Peking University & Chinese Academy of Sciences.
Playing God? The double-edged sword of DNA Daniel Coral 004C MEI.
HFEA Medical Ethics: Embryo. Learning Intentions 0 Be able to explain the legal status of the human embryo in UK law. 0 Be able to describe the role of.
Genetic Disorders and Genetic Testing © 2010 Project Lead The Way, Inc.Medical Interventions.
Key study: Holland et al (1988) Aim: – To examine if there is a higher concordance rate between MZ twins than DZ twins for AN – MZ twins share 100% of.
Who is Gregor Mendel?  The father of “modern genetics”  First studied inheritance patterns using garden pea plants  He observed that traits were inherited.
Designer Babies Adam Ibrahim Anjellica Williams Brooke Formby, Krystel Seguismundo Nicole Bravo, Valeria Simonetti.
Personal DNA Testing Melanie Wark Mackenzie Steen.
Genome editing: What lessons can we learn from the mitochondrial donation debate? Peter Thompson Human Fertilisation & Embryology Authority.
ETHICS IN BIOMEDICAL ENGINEERING BY RYAN IVONE. INTRODUCTION Goal : Use their knowledge, skills, and abilities to enhance the safety, health, and welfare.
Gene flow and speciation. Mechanism for speciation Allopatric speciation Sympatric speciation.
The hope (and hype) of reproductive technologies: mitochondria disease and techniques of mitochondria donation Dr Rebecca Dimond
What do we need to know to become stem cell literate?
ETHICAL ISSUES OF RESEARCH ON HUMAN BIOLOGICAL MATERIALS
Gene Editing: Ethics and Governance
On Human Gene Editing: International Summit Statement
7.L.4A.6 Construct scientific arguments using evidence to support claims concerning the advantages and disadvantages of the use of technology (such as.
Unit 3.
Genetic Disorders and Genetic Testing
Biotechnology Ms. Hughes Biology.
Different mode and types of inheritance
Nature vs. Nurture & Psychological Development
The Future of Genetic Research
Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.
Identifying Basic Principles for Moving Forward
Regulating Genome Editing in Australia
Islamic Ethical Perspectives on Human Genome Editing
Ethical Dilemmas in Germline Editing: Focusing on Informed Consent
Section 1 Vocabulary Access Biology
Ethical and Policy Issues in Human Germ line Modifications
Genetic Disorders and Genetic Testing
Genome Editing Should we have the option to change DNA in babies?
THE ETHICS OF TRUTH-TELLING IN HEALTHCARE
Presentation transcript:

Ethics of modifying the mitochondrial genome Annelien L. Bredenoord, PhD University Medical Center Utrecht Department of Medical Humanities

Outline 1.Does mitochondrial donation entail germ-line modification? 2.Are there moral differences between germ-line modification of the nuclear DNA and modification of the mtDNA? 3.What are conditions for a responsible use?

Germ-line modification? Several differences nuclear DNA and mtDNA: (1)mtDNA is extremely small (2)mtDNA has very specific function (3)mtDNA has own transmission pattern Not relevant!

Germ-line modification? YES! Germ-line modification refers to any biomedical intervention that modifies the genome that a person can transmit to his/her child and the child’s entire lineage  Novel mtDNA can be transmitted to further generations Bredenoord et al 2008, Hum Reprod Update 14: Bredenoord et al 2011, J Med Ethics 37:97-100

Tenable dichotomy? Modification of the nuclear genome is considered more controversial than modification of the mitochondrial genome. This is because only the nuclear DNA would contain the ingredients for our identity. Tenable dichotomy?

Modification mtDNA less controversial? Fear to alter ‘essential’ characteristics of a future person. As the nuclear DNA would contain our identity, modification of the mtDNA would be less controversial. Human Fertilisation and Embryology Authority (HFEA, 2005): “mtDNA is not associated with identity or predetermined characteristics of the individual” Bredenoord et al 2008, Hum Reprod Update 14:

Contestable assumption! (1) Little is known about the exact role, significance and function of the mtDNA. Studies have questioned the assumption that mtDNA is not associated with essential characteristics (Nagao et al, 1997; Roubertoux et al, 2003; Moreno-Loshuertos et al, 2006; Waters, cited in Frankel and Hagen, 2011) (2) None of the key terms are defined. What constitutes ‘identity’, ‘essential’ or ‘predetermined’ characteristics?  Does modification of the mtDNA alter the identity of the person born?

Does germ-line modification of the mtDNA affect the identity of the person born? Qualitative identity: two persons or objects are exactly alike Numerical identity: two persons or objects are one and the same Parfit, 1984; Ossorio, 2003; DeGrazia, 2005; Bredenoord et al, J Med Ethics (2011)

Does germ-line modification of the mtDNA affect the identity of the person born? Even if the mtDNA has a basic cellular role then still it is meaningful to say that germ-line modification of the mtDNA will change the (qualitative) identity of the future person. After the modification, the future person will no longer be exactly alike After all, without the mtDNA disease the child will have: -A different life experience -A different biography -A different character(?) Bredenoord et al 2011, J Med Ethics 37:97-100

Does germ-line modification of the mtDNA affect the identity of the person born? This means that the dichotomy between modification of the nDNA and modification of the mtDNA is untenable from this perspective: no matter whether one modifies a (pathogenic) nuclear gene or a (pathogenic) mitochondrial gene, the identity of the future person will be changed.

Does germ-line modification of the mtDNA affect the identity of the person born? This is not to say that the distinction may not be relevant from other perspectives. But modification of the mtDNA cannot be considered substantively different to modification of the nuclear DNA in terms of its effects on the identity of the future person. Bredenoord et al 2011, J Med Ethics 37:97-100

Is germ-line modification compatible with the right to an open future? Habermas (2003): ‘genetic modification may entail a prejudgment of specific life projects, which may imperil autonomy. Choosing the genetic make-up of a child may violate its right to an open future’ In a pluralist liberal society, one should indeed allow people to be the authors of their lives.  Does germ-line modification of the mtDNA potentially threaten the child’s right to an open future?

General purpose means Only allow modifications that broaden ‘general purpose means’ (Buchanan et al, 2000): capacities that are useful and valuable for carrying out nearly all plans of life Health is a sine qua non for many (though not all) plans of life

Germ-line modification Modification of the mtDNA is not substantively different from modification of the nuclear DNA in terms of its effects on the identity of the future person. Therefore, any conclusion regarding the moral acceptability of modifying the mtDNA applies mutatis mutandis to modification of the nuclear genome. This means that modification of the nuclear genome is equally acceptable as long as, other things being equal, this does not violate the child’s right to an open future. Bredenoord et al 2011, J Med Ethics 37:97-100

Conclusion 1.Modification of the mtDNA entails germ-line modification 2.Modification of the mtDNA has identity-altering potential 3.The dichotomy between modification of the mtDNA and nuclear DNA is untenable from this perspective: all germ-line modifications change identity 4.Germ-line modification could be morally acceptable under certain conditions.

Conditions for a responsible use I. Germ-line modification should not violate the child’s right to an open future II. Safety and efficacy: examine the ethics of first human use

Conditions for a responsible use Bredenoord and Braude 2010, BMJ 341:c6021

Thank you Annelien L. Bredenoord University Medical Center Utrecht The Netherlands